Author

Xuyang Li

Johns Hopkins UniversityORCID 0009-0007-2405-9890Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xuyang Li1 paper · Howard Hughes Medical Institute

Biology Disciplines

Click to filter author papers

Immunology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

Dan Hu· 1 shared Haili ZhangiD· 1 shared Howard L. WeineriD· 1 shared Jie Dou· 1 shared Jie SheniD· 1 shared Lin YangiD· 1 shared Martin HembergiD· 1 shared Mengdi LiangiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Dan Hu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 17, 2026

NKG2C+CD27- Defines Human CD8+ Regulatory T Cells

Xuyang Li, Somen K Mistri, Tian Cao…·Dan Hu

The paper identifies NKG2C+CD27- as a novel marker for CD8+ regulatory T cells, revealing their clonality and functional subsets, and highlights their heterogeneity in aging.

DOI 10.64898/2026.06.15.732401

humanflow cytometry

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintApr 24, 2023

Integration of microbial and chemical synthesis for the efficient production of plitidepsin, a promising anticancer and antiviral agent

Haili Zhang, Zhen Hui, Mingwei Cai…·Xiaoyu Tang

This paper combines microbial and chemical synthesis to efficiently produce plitidepsin, achieving high yields and new analogues with anticancer and antiviral activities.

3 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky